翰宇药业前三季度净利7135.15万元，同比增长305%

Core Insights - Hanyu Pharmaceutical reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong financial performance [1] Financial Performance - The company's operating revenue for the first three quarters reached 683 million yuan, representing a year-on-year growth of 82.06% [1] - The net profit attributable to shareholders was 71.35 million yuan, showing a remarkable year-on-year increase of 305% [1]